The fifth partner is the group of Dr. Bonnefoy adn Dr. Faget, from @IRCM_MTP @inserm, who, thanks to their expertise on immunotherapeutics, will be in charge on the preclinicsl evaluation of the vaccine.

Moltíssimes gràcies per finançar el nostre projecte TumorOUT , per trobar una #vacuna terapèutica del #càncer de #pulmó basada en #nanomedicina. IQS Barcelona U. Ramon Llull (URL)

📣 L'Associació Associació Contra el Càncer BARCELONA ha concedit finançament al projecte TumorOUT, liderat per la professora i investigadora d'IQS Cristina Fornaguera. L'objectiu del projecte és trobar una vacuna terapèutica contra el càncer de pulmó basada en nanomedicina. Moltes gràcies! 👏🏼

#DonesRecerca 🟣La Dra. Cristina Fornaguera, professora d’IQS, coordina el projecte europeu TumorOUT, que té com a objectiu dissenyar una vacuna terapèutica pel càncer de pulmó basada en la revolucionària tecnologia de vacunes de mRNA amb nanopartícules. bit.ly/3kYdhNh

The last partner is the group of Dr. Niehaus and Dr. Bednarz, from CeBiTec Bielefeld University . They are experts on advanced imaging techniques, so they will characterize the nanoparticles biodistribution in vivo.

Don't forget to check out the full article by María Navalón, Aurora Dols-Perez, Cristina Fornaguera and colleagues at pubs.rsc.org/en/content/art…

The Asociación Española Contra el Cáncer highlights our project through an interview with the project. coordinator, Dr. Cristina Fornaguera . Read it! ⬇️

Have you ever seen a human immature #eosinophil at high resolution? Here it is one in the middle stage of development captured by electron microscopy. Learn more in our Atlas: tinyurl.com/ultrastructure #MicroscopyMonday #sciart

CRS Membership for the Remainder of 2023! 😀Register today! ow.ly/C27Z50PGu0B When you register for the Women's Health Symposium, you receive CRS membership for the remainder of 2023! #crs #deliveryscience #women #womenshealth #WomenHealthSymposium

Nature research paper: Epitope editing enables targeted immunotherapy of acute myeloid leukaemia go.nature.com/44wcHae

Read the new paper from one of our partners,Cristina Fornaguera lab from IQS Barcelona and U. Ramon Llull (URL), reporting on the hierarchical assembly of anticancer drug Doxorubicin inside capsules and the influence of preparation methods and electrolytes. 😱

Are you interested in #polymeric #nanoparticles for 🫁 cancer therapies? Come to see the poster presentarion, by our PhD student Toni Torres Coll this afternoon art @ESB2023 🔝🔝

Our coordinator Cristina Fornaguera is ready to explain our project!

🎉Check out the final Community Spotlight blog in our J. Mater. Chem. family 10th Anniversary series! Find out more about some of our first time corresponding authors who have published with us and have their work featured in our #MyFirstJMC collections! blogs.rsc.org/jm/2023/12/05/…

Remembering the Transcan-3 JTC2021 Kick-off Symposium, where Cristina Fornaguera, coordinator of our consortium, presented the goals and firsts results of our project, on #LungCancer #mRNA #vaccination

We are hiring‼️📌🗣 If you are interested in joining us as a professor in Medicinal or Bioorganic Chemistry, do not hesitate to apply: IQS Barcelona could be your future place for research 👩‍🔬🧑‍🔬and teaching👩‍🎓🧑‍🎓! eur03.safelinks.protection.outlook.com/?url=https%3A%…

A research paper of #mRNA #vaccines from our coordinator highlighted as one of the most cited. Congrats!

Last week, our consortium had the second meeting of the project in Bielefeld. Great days sharing results of each partner.

And with it, our younger members also performed a Workshop on MALDI-MSI.

🫁 Our last consortium meeting ended with impressive good results and plenty of new ideas. 🛜 Stay tunned for news in the next months!